SCHEMBL19299516

SCHEMBL19299516

Cc1ccc(C(=O)NNC(=S)NC(=O)c2ccco2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 1.00
KMT2A Q03164 4/20 1.00
LMNA P02545 3/20 1.00
CRHBP P24387 1/20 1.00
CRHR2 Q13324 1/20 1.00
SMN1; SMN2 Q16637 4/20 0.76
RAB9A P51151 2/20 0.76
NPC1 O15118 1/20 0.76
MAPT P10636 8/20 0.76
GAA P10253 7/20 0.75
HTT P42858 5/20 0.75
CYP2C9 P11712 3/20 0.75
RECQL P46063 1/20 0.75
MEN1 O00255 2/20 0.70
ALDH1A1 P00352 4/20 0.66
CCR6 P51684 1/20 0.66
NLRP1 Q9C000 1/20 0.65
HSP90AA1 P07900 1/20 0.62
AGTR1 P30556 1/20 0.62
HPGD P15428 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19299695 0.86 KDM4E (1.00) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL19294486 0.86 MAPT (1.00) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL19294488 0.84 KDM4E (0.72) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL19294498 0.82 KDM4E (1.00) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL19299514 0.82 KDM4E (1.00) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL19299652 0.81 MAPT (1.00) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL19299513 0.81 KDM4E (0.79) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL5446600 0.81 ALDH1A1 (0.78) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL19299372 0.81 KMT2A (1.00) KDM4EKMT2ALMNACRHBPCRHR2
SCHEMBL19294519 0.80 GAA (0.67) KDM4EKMT2ALMNACRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3212183-B1 SYNERGISTIC COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS UNIV ROCHESTER (US) 2019-10-02 EP disclosed
US-10028931-B2 Synergistic compositions for treating microbial infections UNIVERSITY OF ROCHESTER (US) 2018-07-24 US disclosed
US-20170246139-A1 SYNERGISTIC COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS UNIVERSITY OF ROCHESTER (US) 2017-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10028931-B2 Synergistic compositions for treating microbial infections RNASE1, RNASEL, RNASEH1 KDM4E 2925/4885KMT2A 2906/4885LMNA 2478/4885
US-20170246139-A1 SYNERGISTIC COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS RNASE1, RNASEL, RNASEH1 KDM4E 2925/4885KMT2A 2906/4885LMNA 2478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.